Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Bruce D. Lindsay is Section Head, Cardiac Electrophysiology and Pacing at the Cleveland Clinic. He served as President of the Heart Rhythm Society 2007-2008 and chaired the Heart Rhythm Society's Annual Scientific Program in Boston in 2006, which was attended by more than 13,000 international physicians, scientists, and allied health professionals. Dr. Lindsay recently completed a term on Board of Trustees for the American College of Cardiology, and formerly chaired the College's Board of Governors. He also serves on the ABIM test writing committee for Clinical Cardiac Electrophysiology.
Dr. Lindsay is a graduate of Jefferson Medical College and completed a residency in internal medicine at the University of Michigan. He served in the National Health Service Corps from 1980-83. He completed a cardiology fellowship at Washington University where he undertook additional training in the treatment of heart rhythm disorders. He joined the faculty at Washington University in 1985 and became Professor of Medicine and Director of Electrophysiology. He accepted the position of Section Head, Cardiac Electrophysiology and Pacing at the Cleveland Clinic in 2008.
His clinical research and publications have focused on identification of patients at increased risk for cardiac arrest, improved technology for implantable defibrillators, malfunctions of implantable cardiac devices, and advances in ablation of heart rhythm abnormalities. He is a contributing author for the Heart Rhythm Society state of the art consensus document for ablation of atrial fibrillation. Through his commitment to education he has served on the faculty at meetings throughout the United States, Europe, Japan, Taiwan, and China.
Abnormal Heart Rhythms, Long QT Syndrome, Atrial Fibrillation, Supraventricular Tachycardia, Sudden Cardiac Death, Ventricular Tachycardia, Biventricular Pacemaker, Catheter Ablation, Implantable Cardioverter Defibrillator, Pacemaker Implant, Pulmonary Vein Isolation Ablation
Innovations & Patents
Magnetic catheter navigation for ablation of atrial and ventricular arrhythmias
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Lindsay's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.